HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuro-Ophthalmic Visual Impairment in the Setting of COVID-19.

Abstract
We set out to describe in detail the afferent neuro-ophthalmological complications that have been reported in association with coronavirus disease 2019 (COVID-19) infection. We describe and elaborate on mechanisms of disease, including para-infectious inflammation, hypercoagulability, endothelial damage, and direct neurotropic viral invasion. Despite global vaccination programs, new variants of COVID-19 continue to pose an international threat, and patients with rare neuro-ophthalmic complications are likely to continue to present for care.Afferent complications from COVID-19 include homonymous visual field loss, with or without higher cortical visual syndromes, resulting from stroke, intracerebral hemorrhage, or posterior reversible leukoencephalopathy. Optic neuritis has frequently been reported, sometimes along with acute disseminated encephalomyelopathy, often in association with either myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) or less commonly aquaporin-4 seropositivity or in newly diagnosed multiple sclerosis. Ischemic optic neuropathy has rarely been reported. Papilledema, resulting either from venous sinus thrombosis or idiopathic intracranial hypertension in the setting of COVID-19, has also been described.Observed afferent neuro-ophthalmic associations need to be confirmed though larger comparative studies. Meanwhile, the range of possible complications should be recognized by neurologists and ophthalmologists alike, to facilitate faster diagnosis and treatment of both COVID-19 and its neuro-ophthalmic manifestations.
AuthorsMarc Dinkin, Swetha Sathi
JournalSeminars in neurology (Semin Neurol) Vol. 43 Issue 2 Pg. 268-285 (04 2023) ISSN: 1098-9021 [Electronic] United States
PMID37311536 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightThieme. All rights reserved.
Chemical References
  • Myelin-Oligodendrocyte Glycoprotein
  • Autoantibodies
Topics
  • Humans
  • Myelin-Oligodendrocyte Glycoprotein
  • Retrospective Studies
  • COVID-19 (complications)
  • Optic Neuritis (diagnosis, etiology, therapy)
  • Vision Disorders (diagnosis, etiology)
  • Autoantibodies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: